Clinical impact of Hypofractionated carbon ion radiotherapy on locally advanced hepatocellular carcinoma
Abstract Background Hepatocellular carcinoma (HCC) involving a major branch of the portal or hepatic vein is in a locally advanced stage and remains difficult to cure. This study aimed to evaluate the clinical effects of carbon ion radiotherapy (C-ion RT) in locally advanced HCC (LAHCC). Methods The...
Main Authors: | Shintaro Shiba, Kei Shibuya, Masahiko Okamoto, Shohei Okazaki, Shuichiro Komatsu, Yoshiki Kubota, Takashi Nakano, Tatsuya Ohno |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-08-01
|
Series: | Radiation Oncology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13014-020-01634-z |
Similar Items
-
Long-term outcomes of the 2-week schedule of hypofractionated radiotherapy for recurrent hepatocellular carcinoma
by: Jongmoo Park, et al.
Published: (2018-10-01) -
The Role of Radical Dose of Radiotherapy in Hepatocellular Carcinoma
by: Maher Soliman
Published: (2022-07-01) -
Hypofractionated Radiotherapy for Hematologic Malignancies during the COVID-19 Pandemic and Beyond
by: Febin Antony, et al.
Published: (2024-01-01) -
Hypofractionated Radiotherapy in African Cancer Centers
by: William Swanson, et al.
Published: (2021-02-01) -
Conventional versus different hypofractionated radiotherapy dosage schedules in postmastectomy advanced breast cancer
by: Neeraj Jain, et al.
Published: (2022-01-01)